# Personalized Tumor Neoantigen Peptide Vaccine Combined with Radiotherapy in the Treatment of Advanced Tumors - Phase II Randomized Group Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/personalized-tumor-neoantigen-peptide-vaccine-combined-with-radiotherapy-in-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Zhang,Rutao Li,Y. Hu,Wei Dai,J. Wang,Zhaoqiang Xu,Xiangqian Su,J. Huang,Feng-Wei Kong |
| Citations | 0 |
| DOI | 10.1016/j.ijrobp.2024.07.1976 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4402908739 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Rutao Li](https://scholariq.org/researchers/rutao-li/)

## Paper journal

- [International Journal of Radiation Oncology*Biology*Physics](https://scholariq.org/journals/international-journal-of-radiation-oncology-biology-physics/)

## Paper primary topic

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Paper topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.